{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:48:35Z","timestamp":1791103715102,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ijantimicag.2004.08.019","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T17:32:50Z","timestamp":1110562370000},"page":"302-307","source":"Crossref","is-referenced-by-count":49,"title":["Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing"],"prefix":"10.1016","volume":"25","author":[{"given":"Janet E.","family":"Stout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Sens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Mietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Obman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.08.019_bib1","series-title":"Antimicrobial therapy and vaccines","first-page":"395","article-title":"Legionella pneumophila","author":"Sabria","year":"2002"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib2","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1378\/chest.125.6.2135","article-title":"Levofloxacin efficacy in the treatment of community-acquired legionellosis","volume":"125","author":"Yu","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/48.suppl_2.25","article-title":"Activity of telithromycin, a new ketolide antibacterial against atypical and intracellular respiratory tract pathogens","volume":"48","author":"Hammerschlag","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0924-8579(99)00057-6","article-title":"Activity of grepafloxacin and other fluoroquinolones against recent clinical isolates of Chlamydia pneumoniae","volume":"12","author":"Roblin","year":"1999","journal-title":"Int J Antimicrob Agent"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.32.10.1500","article-title":"In vitro susceptibility of mycoplasmas to new macrolides and aryl-fluoroquinolones","volume":"32","author":"Waites","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib6","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5","year":"2002"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/23.1.37","article-title":"Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions","volume":"23","author":"Liebers","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(97)00174-0","article-title":"Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells","volume":"30","author":"Stout","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/41.2.289","article-title":"Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin\/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells","volume":"41","author":"Stout","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/45.suppl_3.41","article-title":"Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp","volume":"45","author":"DuBois","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/40.3.427","article-title":"In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against Gram-positive and Gram-negative pathogens from respiratory tract infections","volume":"40","author":"Hoogkamp-Korstanje","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.40.6.1419","article-title":"In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella","volume":"40","author":"Martin","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/AAC.43.1.90","article-title":"In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs and use of the drugs to treat guinea pigs with Legionella pneumophila pneumonia","volume":"43","author":"Edelstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/BF01691575","article-title":"A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs","volume":"17","author":"Garcia-de-Lomas","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/46.3.385","article-title":"The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo","volume":"46","author":"Jonas","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dkf017","article-title":"Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila","volume":"49","author":"Jung","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/32.1.93","article-title":"Comparative study of the bactericidal activity of ampicillin\/sulbactam and erythromycin against intracellular Legionella pneumophila","volume":"32","author":"Ramirez","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/46.4.589","article-title":"Evaluation of human monocytic cell line THP-1 model for the intracellular activities of antimicrobial agents against Legionella pneumophila","volume":"46","author":"Takemura","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0934-8840(97)80009-6","article-title":"Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages","volume":"285","author":"Walz","year":"1997","journal-title":"Zbl Bakt"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib20","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.144.7.2738","article-title":"The HL-60 model for the interaction of human macrophages with the Legionnaires\u2019 disease bacterium","volume":"144","author":"Marra","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jlb.54.1.40","article-title":"Intracellular multiplication of Legionella pneumophila in HL-60 cells differentiated by 1,25-dihydroxy-vitamin D and the effect of interferon-gamma","volume":"54","author":"Watanabe","year":"1993","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib22","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.45.8.2204-2209.2001","article-title":"In vitro activity of gemifloxacin (SB-265805, LB 20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia","volume":"45","author":"Edelstein","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/46.1.51","article-title":"Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila","volume":"46","author":"Baltch","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1469-0691.2002.00392.x","article-title":"In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia pneumoniae from North America and Europe","volume":"8","author":"Critchley","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib25","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, randomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2004.08.019_bib26","first-page":"25","article-title":"Clinical efficacy of new antibacterial therapies in at-risk populations","volume":"44","author":"Lorenz","year":"2002","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2004.08.019_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1469-0691.2003.00678.x","article-title":"Telithromycin 800mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia","volume":"9","author":"Carbon","year":"2003","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:43:23Z","timestamp":1683045803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905000270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0924857905000270"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.08.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}